Accuracy of life tables in predicting overall survival in patients after radical prostatectomy

BJU International

Volumn 102, Issue 1, 2008, Pages 33-38

  Walz, Jochen ^a,c   Suardi, Nazareno ^a,e   Shariat, Shahrokh F ^f   Jeldres, Claudio ^a,b   Perrotte, Paul ^b   Graefen, Markus ^d   Widmer, Hughes ^b   Arjane, Philippe ^b   Valiquette, Luc ^b   Hutterer, Georg ^a,g   Saad, Fred ^b   Karakiewicz, Pierre I ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Prostate Cancer Center   (Germany)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Comorbidity; Life tables; Life expectancy; Prostate cancer; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; HUMAN; KAPLAN MEIER METHOD; LIFE EXPECTANCY; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RECURRENT DISEASE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; HUMANS; LIFE EXPECTANCY; LIFE TABLES; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 44849098379     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07614.x     Document Type: Article

References (27)

1. Aus G, Abbou CC, Bolla M et al. EAU guidelines on prostate cancer. Eur Urol 2005 48 : 546 51
2. Scardino P. Update: NCCN prostate cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 2005 3 (Suppl. 1 S29 33
3. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005 293 : 2095 101
4. Judge A, Evans S, Gunnell DJ, Albertsen PC, Verne J, Martin RM. Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of Hospital Episodes Statistics for England. BJU Int 2007 100 : 1040 9
5. Ruchlin HS, Pellissier JM. An economic overview of prostate carcinoma. Cancer 2001 92 : 2796 810
6. Ficarra V, Novara G, Galfano A et al. Twelve-month self-reported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36). BJU Int 2006 97 : 274 8
7. Abrahamsson PA. Active surveillance vs radical prostatectomy. BJU Int 2007 100 (Suppl. 2 26 8
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 : 373 83
9. Hall WH, Jani AB, Ryu JK, Narayan S, Vijayakumar S. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 2005 8 : 22 30
10. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993 32 : 382 7
11. Statistics Canada. Complete Life Table. Quebec: Males. Available at: http://www.statcan.ca 1995-97: Cat 84-537: 27-9
12. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 15 : 361 87
13. American Cancer Society. Cancer Facts and Figures 2006. American Cancer Society, 2006. http://www.cancer.org/docroot/STT/content/ STT_1x_Cancer_Facts_and_Figures_2006.asp
14. McDavid K, Lee J, Fulton JP, Tonita J, Thompson TD. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep 2004 119 : 174 86
15. Postma R, Schroder FH, van Leenders GJ et al. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Section Rotterdam. A comparison of two rounds of screening. Eur Urol 2007 52 : 89 97
16. de Vries SH, Postma R, Raaijmakers R et al. Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam. Eur Urol 2007 51 : 366 74
17. Parker C, Muston D, Melia J, Moss S, Dearnaley D. A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. Br J Cancer 2006 94 : 1361 8
18. Davison BJ, So AI, Goldenberg SL. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int 2007 100 : 780 5
19. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 1993 31 : 141 54
20. Miller MD, Paradis CF, Houck PR et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992 41 : 237 48
21. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974 27 : 387 404
22. Boulos DL, Groome PA, Brundage MD et al. Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent. Cancer 2006 106 : 1804 14
23. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995 274 : 626 31
24. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 1996 156 : 127 32
25. Arredondo SA, Elkin EP, Marr PL et al. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology 2006 67 : 559 65
26. Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006 175 : 99 103
27. Tewari A, Johnson CC, Divine G et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004 171 : 1513 9